Pre-market stock movers are a hot topic among traders on Thursday, and we’re offering all of the latest coverage!
Moving stocks are acquisition deals, mergers, an asset sale and more.
Let’s get into that news below!
Biggest Pre-蜜桃传媒 Stock Movers: 10 Top Gainers
- OpGen (NASDAQ:OPGN) stock is rocketing more than 757% alongside and .
- Secoo (NASDAQ:SECO) shares are soaring over 440% alongside heavy pre-market trading.
- Reshape Lifesciences (NASDAQ:RSLS) stock is surging more than 174% with strong early morning trading.
- Jaguar Health (NASDAQ:JAGX) shares are rising over 73% as it .
- Bsquare (NASDAQ:BSQR) stock is increasing more than 47% .
- Biocept (NASDAQ:BIOC) shares are gaining close to 31% on Thursday morning.
- Werewolf Therapeutics (NASDAQ:HOWL) stock is climbing nearly 30% despite a lack of news this morning.
- Versus Systems (NASDAQ:VS) shares are getting an almost 27% boost with heavy pre-market trading.
- Tantech (NASDAQ:TANH) stock is jumping over 26% on Thursday morning.
- Genetron (NASDAQ:GTH) shares are up more than 24% after to take it private.
10 Top Losers
- Tempest Therapeutics (NASDAQ:TPST) stock is crashing over 35% following .
- Phio Pharma (NASDAQ:PHIO) shares are plummeting more than 30% after yesterday.
- Agape ATP (NASDAQ:ATPC) stock is diving over 29% after .
- Wheeler Real Estate IT (NASDAQ:WHLR) shares are retreating more than 22% after a Wednesday rally.
- Gaucho Group (NASDAQ:VINO) stock is tumbling over 18% after rallying yesterday.
- Clearmind Medicine (NASDAQ:CMND) shares are taking a more than 18% beating .
- AgileThought (NASDAQ:AGIL) stock is sliding close to 18% on Thursday morning.
- BioCardia (NASDAQ:BCDA) shares are decreasing 17% following a rally .
- Hub Cyber Security (NASDAQ:HUBC) stock is dropping over 16% after a recent rally.
- Shift Technologies (NASDAQ:SFT) shares close out our pre-market stock movers down more than 15% after a .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
